About the Authors
- Lena Bengestrate
-
Current address: Institute for Biochemistry II, University of Cologne, Cologne, Germany
Affiliation Department of Epigenetics, QIAGEN GmbH, Hilden, Germany
- Sam Virtue
-
Affiliation Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom
- Mark Campbell
-
Affiliation Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom
- Antonio Vidal-Puig
-
Affiliation Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom
- Dirk Hadaschik
-
Affiliation Department of Epigenetics, QIAGEN GmbH, Hilden, Germany
- Peter Hahn
-
Affiliation Department of Epigenetics, QIAGEN GmbH, Hilden, Germany
- Wolfgang Bielke
-
* E-mail: wolfgang.bielke@qiagen.com
Affiliation Department of Epigenetics, QIAGEN GmbH, Hilden, Germany
Competing Interests
The authors DH, PH, and WB are currently employees within the R&D department of QIAGEN GmbH and declare potential competing financial interests, including personal ownership of QIAGEN stocks and/or stock options. Several commercially available products, marketed by QIAGEN, were employed for this study. These products include kits and items for nucleic acid isolation and amplification, as well as the miScript system for microRNA detection. QIAGEN holds several issued and pending patents related to these products. The above said does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LB SV MC AV-P DH PH WB. Performed the experiments: LB SV MC PH. Analyzed the data: LB SV MC AV-P DH PH WB. Contributed reagents/materials/analysis tools: SV MC AV-P. Wrote the paper: LB PH DH WB.